Omega Fund Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
|
|||||
2024
Q4 | $57.8K | Hold |
|
|||||
2024
Q3 | $540K | Hold |
|
|||||
2024
Q2 | $1.3M | Hold |
|
|||||
2024
Q1 | $1.34M | Hold |
|
|||||
2023
Q4 | $1.96M | Hold |
|
|||||
2023
Q3 | $993K | Hold |
|
|||||
2023
Q2 | $792K | Hold |
|
|||||
2023
Q1 | $671K | Hold |
|
|||||
2022
Q4 | $902K | Hold |
|
|||||
2022
Q3 | $1.62M | Sell |
|
|||||
2022
Q2 | $2.42M | Hold |
|
|||||
2022
Q1 | $2.99M | Hold |
|
|||||
2021
Q4 | $8.19M | Hold |
|
|||||
2021
Q3 | $11.2M | Buy |
|
|||||
2021
Q2 | $12.4M | Buy |
|
|||||
2021
Q1 | $11.7M | Hold |
|
|||||
2020
Q4 | $17M | Buy |
|